These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30092787)

  • 1. Morning blood pressure surge and its relation to insulin resistance in patients of reproductive age with polycystic ovary syndrome.
    Kadi H; Avci E; Usta A; Demirtaş AO
    Reprod Biol Endocrinol; 2018 Aug; 16(1):75. PubMed ID: 30092787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome.
    Kuppusamy S; Pal GK; Habeebullah S; Ananthanarayanan PH; Pal P
    Endocr Res; 2015; 40(1):37-43. PubMed ID: 24866562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nesfatin-1 and Vitamin D levels may be associated with systolic and diastolic blood pressure values and hearth rate in polycystic ovary syndrome.
    Sahin FK; Sahin SB; Ural UM; Cure MC; Senturk S; Tekin YB; Balik G; Cure E; Yuce S; Kirbas A
    Bosn J Basic Med Sci; 2015 Jul; 15(3):57-63. PubMed ID: 26295295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance].
    Wan DH; Fan P; Bai H; Song Q; Liu HW
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated diastolic blood pressure in insulin-resistant polycystic ovarian syndrome patients.
    da Silva AM; de Andrade AC; Dias BH; da Silva Medeiros MA; Rao VS; das Chagas Medeiros F
    Arch Gynecol Obstet; 2014 Jan; 289(1):119-22. PubMed ID: 23860693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome.
    Battaglia C; Mancini F; Cianciosi A; Busacchi P; Facchinetti F; Marchesini GR; Marzocchi R; de Aloysio D
    Obstet Gynecol; 2008 Feb; 111(2 Pt 1):385-95. PubMed ID: 18238977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
    Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
    Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of serum granzyme-B is associated with insulin resistance and increased cardiovascular risk in adolescent polycystic ovary syndrome patients.
    Oztas E; Ozler S; Tokmak A; Yilmaz N; Celik HT; Kazancı FH; Danisman N; Ergin M; Yakut HI
    Eur J Obstet Gynecol Reprod Biol; 2016 Mar; 198():89-93. PubMed ID: 26802256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters.
    Durmus U; Duran C; Ecirli S
    J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance according to β-cell function in women with polycystic ovary syndrome and normal glucose tolerance.
    Song DK; Hong YS; Sung YA; Lee H
    PLoS One; 2017; 12(5):e0178120. PubMed ID: 28542421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C; McGrath BP; Teede HJ
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinsulinemia and obese phenotype differently influence blood pressure in young normotensive patients with polycystic ovary syndrome.
    Mioni R; Cà AD; Turra J; Azzolini S; Xamin N; Bleve L; Maffei P; Vettor R; Fallo F
    Endocrine; 2017 Feb; 55(2):625-634. PubMed ID: 27142411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.
    Sahin I; Celik O; Celik N; Keskin L; Dogru A; Dogru I; Yürekli M; Yologlu S
    J Endocrinol Invest; 2012 Jun; 35(6):553-6. PubMed ID: 21791966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
    Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
    Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance.
    Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M
    J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin ameliorates endothelial dysfunction and insulin resistance in Tibet women with polycystic ovary syndrome.
    Yang B; Sun ZJ; Chen B; Zhang J; Zhao H; Li CW; Cao YK; Cao F
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1185-91. PubMed ID: 27049276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.